Infecções Respiratórias Virais na Sazonalidade e o Impacto para o Prematuro

A infecção respiratória viral é uma realidade frequente no seguimento de prematuros e o Vírus Sincicial Respiratório (VSR) é o patógeno mais comum, seguido de Rinovírus, Parainfluenza vírus, Metapneumo vírus, Influenza vírus, Adenovírus, Coronavírus e Bocavírus humano.

Download da apresentação em: <https://www.arca.fiocruz.br/handle/icict/49470>

Conteúdo Relacionado

• Postagem – Prevenção de Infecção pelo Vírus Sincicial Respiratório (VSR) em Unidades Neonatais e na Comunidade
• Encontro com Especialista – Viroses Respiratórias Sazonais no Seguimento do RN de Risco
• Postagem – Principais Questões sobre Viroses Respiratórias na Infância em tempos de COVID-19
• Postagem – Principais questões sobre sobre Aleitamento Materno na Unidade Neonatal

Referências citadas

• Jobe A. H. (2011). The new bronchopulmonary dysplasia. Current opinion in pediatrics, 23(2), 167–172.
• Short EJ, Klein NK, Lewis BA, et al. Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics. 2003;112(5):e359. doi:10.1542/peds.112.5.e359
• van Mastrigt E, Logie K, Ciet P, et al. Lung CT imaging in patients with bronchopulmonary dysplasia: A systematic review. Pediatr Pulmonol. 2016;51(9):975-986. doi:10.1002/ppul.23446
• Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009 Feb 5;360(6):588-98. doi: 10.1056/NEJMoa0804877. PubMed PMID: 19196675; PubMed Central PMCID: PMC4829966.
• Mazur NI, Martinón-Torres F, Baraldi E, et al. Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med. 2015;3(11):888-900. doi:10.1016/S2213-2600(15)00255-6
• Mukherjee, Sumanta et al. “IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.” The American journal of pathology vol. 179,1 (2011): 248-58. doi:10.1016/j.ajpath.2011.03.003
• Shi T, McAllister DA, O’Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946-958. doi:10.1016/S0140-6736(17)30938-8
• Mauskopf J, Margulis AV, Samuel M, Lohr KN. Respiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants: Systematic Review. Pediatr Infect Dis J. 2016;35(7):e229-e238. doi:10.1097/INF.0000000000001163
• Scheltema NM, Gentile A, Lucion F, et al. Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series [published correction appears in Lancet Glob Health. 2017 Dec;5(12 ):e1190]. Lancet Glob Health. 2017;5(10):e984-e991. doi:10.1016/S2214-109X(17)30344-3
• Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000;13(3):371-384. doi:10.1128/cmr.13.3.371-384.2000
• Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749-1759. doi:10.1056/NEJMoa043951
• Langston C, Kida K, Reed M, Thurlbeck WM. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis. 1984;129(4):607-613.
• Colin AA, McEvoy C, Castile RG. Respiratory morbidity and lung function in preterm infants of 32 to 36 weeks’ gestational age. Pediatrics. 2010;126(1):115-128. doi:10.1542/peds.2009-1381
• Goedicke-Fritz, Sybelle et al. Preterm Birth Affects the Risk of Developing Immune-Mediated Diseases. Frontiers in immunology vol. 8 1266. 9 Oct. 2017, doi:10.3389/fimmu.2017.01266
• Von Holle TA, Moody MA. Influenza and Antibody-Dependent Cellular Cytotoxicity. Front Immunol. 2019;10:1457. Published 2019 Jun 25. doi:10.3389/fimmu.2019.01457
• Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Portaria Conjunta Nº23, de 3 de Outubro de 2018. Aprova o Protocolo de Uso do Palivizumabe para a Prevenção da Infecção pelo Vírus Sincicial Respiratório.
• Bont L, Checchia PA, Fauroux B, et al. Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries. Infect Dis Ther. 2016;5(3):271-298. doi:10.1007/s40121-016-0123-0
• Andabaka T, Nickerson JW, Rojas-Reyes MX, Rueda JD, Bacic Vrca V, Barsic B. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev. 2013;(4):CD006602. Published 2013 Apr 30. doi:10.1002/14651858.CD006602.pub4
• Villamor-Martínez E, Pierro M, Cavallaro G, Mosca F, Villamor E. Mother’s Own Milk and Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis. Front Pediatr. 2019;7:224. Published 2019 Jun 6. doi:10.3389/fped.2019.00224
• Hay WW Jr. Nutritional Support Strategies for the Preterm Infant in the Neonatal Intensive Care Unit. Pediatr Gastroenterol Hepatol Nutr. 2018;21(4):234-247. doi:10.5223/pghn.2018.21.4.234